FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Denham

Research Profile

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Geographic Areas

Australia

Anatomy

Skin

Co-author Network

Publications

TOP 3
Rachel Kearvell; David Lamb; Judy Murray; Sharon Richardson; Nigel A Spry; Gillian Duchesne; Martin A Ebert; Annette Haworth; Ben Hooton; David J Joseph; James W Denham
Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
James W Denham; Gillian Duchesne; Nirdosh Kumar Gogna; David Joseph; Lizbeth Kenny; David S Lamb; John Matthews; Nigel Spry; Keen-Hun Tai; Sandra Turner; Chantelle Wilcox; Chris Atkinson; David Christie; Brett Delahunt; Patrick McElduff
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
James W Denham; Gillian Duchesne; Martin Ebert; Nirdosh Kumar Gogna; Chris Atkinson; Brett Delahunt; Lizbeth Kenny; David S Lamb; John Matthews; Patrick McElduff; Nigel Spry; Keen-Hun Tai; Sandra Turner; Chantelle Wilcox; David Joseph
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Denham (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rachel Kearvell; David Lamb; Judy Murray; Sharon Richardson; Nigel A Spry; Gillian Duchesne; Martin A Ebert; Annette Haworth; Ben Hooton; David J Joseph; James W Denham
Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
Journal of medical imaging and radiation oncology 2013;57(2):247-57.
2012: James W Denham; Gillian Duchesne; Nirdosh Kumar Gogna; David Joseph; Lizbeth Kenny; David S Lamb; John Matthews; Nigel Spry; Keen-Hun Tai; Sandra Turner; Chantelle Wilcox; Chris Atkinson; David Christie; Brett Delahunt; Patrick McElduff
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
The lancet oncology 2012;13(12):1260-70.
2012: James W Denham; Gillian Duchesne; Martin Ebert; Nirdosh Kumar Gogna; Chris Atkinson; Brett Delahunt; Lizbeth Kenny; David S Lamb; John Matthews; Patrick McElduff; Nigel Spry; Keen-Hun Tai; Sandra Turner; Chantelle Wilcox; David Joseph
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;105(2):184-92.
2012: Anthony V D'Amico; Mario de Castro; Ming-Hui Chen; Philip W Kantoff; David S Lamb; Marian Loffredo; Allison Steigler; James W Denham
Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials.
The lancet oncology 2012;13(2):189-95.
2012: Allison Steigler; Keen-Hun Tai; Sandra Turner; Chris Atkinson; David Christie; James W Denham; David Joseph; David S Lamb; John Matthews; John North; Nigel Spry; Chris Wynne
Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 Trial.
Prostate cancer 2012;2012():814724.
2012: Chantelle Wilcox; Allison Kautto; Allison Steigler; James W Denham
Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long term.
Oncology 2012;82(1):56-8.
2011: James W Denham; Chris Atkinson; Gillian M Duchesne; Martin Ebert; David Joseph; David S Lamb; John Matthews; Nigel Spry; Allison Steigler; Catherine D'Este
Another form of subgroup to beware.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;101(3):525-6.
2011: K M Harrison; Stephen Howlett; Tomas Kron; D Cornes; Martin A Ebert; C S Hamilton; James W Denham
Design, manufacture, and evaluation of an anthropomorphic pelvic phantom purpose-built for radiotherapy dosimetric intercomparison.
Medical physics 2011;38(10):5330-7.
2011: James W Denham
Targeted therapies: An important piece of the localized prostate cancer puzzle?
Nature reviews. Clinical oncology 2011;8(10):573-4.
2011: Martin A Ebert; C S Hamilton; K M Harrison; Stephen Howlett; David J Joseph; Tomas Kron; M Bulsara; D Cornes; James W Denham
Dosimetric intercomparison for multicenter clinical trials using a patient-based anatomic pelvic phantom.
Medical physics 2011;38(9):5167-75.
2011: James W Denham; Allison Steigler; David S Lamb; David Joseph; Sandra Turner; John Matthews; Chris Atkinson; John North; David Christie; Nigel Spry; Keen-Hun Tai; Chris Wynne; Catherine D'Este
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
The lancet oncology 2011;12(5):451-9.
2011: Joan A Hatton; Peter B Greer; Colin Tang; Philip Wright; Anne Capp; Sanjiv Gupta; Joel Parker; Chris Wratten; James W Denham
Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;98(2):162-8.
2011: Martin A Ebert; David S Lamb; David J Joseph; Allison Steigler; James W Denham
A methodology for the analysis of PSA response signatures.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;98(2):198-202.
2011: David S Lamb; James W Denham; David Joseph; John Matthews; Chris Atkinson; Nigel Spry; Gillian M Duchesne; Martin Ebert; Allison Steigler; Brett Delahunt; Catherine D'Este
A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial.
International journal of radiation oncology, biology, physics 2011;79(2):385-91.
2010: Mahesh Kumar; James W Denham; Allison Steigler
Value of combined androgen blockade in the neoadjuvant treatment of localized prostate cancer: the jury must remain out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):e445-6; author reply e447.
2010: James W Denham; Ron Bender; William E J Paradice
It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials.
The Medical journal of Australia 2010;192(7):393-6.
2009: James W Denham; Allison Steigler; Mahesh Kumar; David S Lamb; David Joseph; Nigel Spry; Keen-Hun Tai; Chris Atkinson; Sandra Turner; Peter B Greer; Paul S Gleeson; Catherine D'Este
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?
International journal of radiation oncology, biology, physics 2009;75(4):1008-12.
2009: James W Denham; Allison Steigler; Chantelle Wilcox; David S Lamb; David Joseph; Chris Atkinson; Keen-Hun Tai; Nigel Spry; Paul S Gleeson; Catherine D'Este
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?
Cancer 2009;115(19):4477-87.
2009: James W Denham; Mahesh Kumar; Paul S Gleeson; David S Lamb; David Joseph; Chris Atkinson; John Matthews; Keen-Hun Tai; Nigel A Spry; David Christie; Sandra Turner; Peter B Greer; Catherine D'Este; Allison Steigler
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer.
International journal of radiation oncology, biology, physics 2009;74(2):404-11.
2009: James W Denham; David S Lamb; David Joseph; John Matthews; Chris Atkinson; Nigel A Spry; Gillian M Duchesne; Martin Ebert; Allison Steigler; Catherine D'Este
PSA response signatures - a powerful new prognostic indicator after radiation for prostate cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(3):382-8.
2009: Anne Capp; Mario Inostroza-Ponta; Dana Bill; Pablo Moscato; Chi Lai; David Christie; David Lamb; Sandra Turner; David Joseph; John Matthews; Chris Atkinson; John North; Michael Poulsen; Nigel A Spry; Keen-Hun Tai; Chris Wynne; Gillian M Duchesne; Allison Steigler; James W Denham
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(3):400-7.
2009: Lisa F Lincz; Sanjiv A Gupta; Christopher R Wratten; Janice Kilmurray; Sharon Nash; Michael Seldon; Peter C O'Brien; Katy J L Bell; James W Denham
Thrombin generation as a predictor of radiotherapy induced skin erythema.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):136-40.
2008: James W Denham; Allison Steigler; Chantelle Wilcox; David S Lamb; David Joseph; Chris Atkinson; John Matthews; Keen-Hun Tai; Nigel A Spry; David Christie; Paul S Gleeson; Peter B Greer; Catherine D'Este
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.
The lancet oncology 2008;9(11):1058-68.
2007: Anthony V D'Amico; James W Denham; Juanita Crook; Ming-Hui Chen; Samuel Z Goldhaber; David S Lamb; David Joseph; Keen-Hun Tai; Shawn Malone; Charles Ludgate; Allison Steigler; Philip W Kantoff
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(17):2420-5.
2007: Anthony V D'Amico; James W Denham; Michel Bolla; Laurence Collette; David S Lamb; Keen-Hun Tai; Allison Steigler; Ming-Hui Chen
Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
Cancer 2007;109(10):2004-10.
2007: Irena Madjar; James W Denham; Prem Rashid
Do women have a role in early detection of prostate cancer? - Lessons from a qualitative study.
Australian family physician 2007;36(5):375-7.
2007: Christopher R Wratten; Peter C O'Brien; Christopher S Hamilton; Dana Bill; Janice Kilmurray; James W Denham
Breast edema in patients undergoing breast-conserving treatment for breast cancer: assessment via high frequency ultrasound.
The breast journal 2007;13(3):266-73.
2007: Irena Madjar; Lea Kacen; Samuel Ariad; James W Denham
Telling their stories, telling our stories: physicians' experiences with patients who decide to forgo or stop treatment for cancer.
Qualitative health research 2007;17(4):428-41.
2006: Claire Hood; Lisa Duggan; S Bazley; James W Denham; Tomas Kron
Miniature LiF:Mg,Cu,P TLDs to study the effect of applicator material in 192-Ir brachytherapy.
Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine 2006;29(4):300-2.
2005: David Christie; James W Denham; Allison Steigler; David Lamb; Sandra Turner; Hedy Mameghan; David Joseph; John Matthews; Ian Franklin; Chris Atkinson; John North; Michael Poulsen; Nigel Spry; Keen-Hun Tai; Chris Wynne; Gillian M Duchesne; Olga Kovacev; Lynne Francis; Andrew Kramar; Catherine D'Este; Dana Bill
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;77(2):117-25.
2005: James W Denham; Allison Steigler; David S Lamb; David Joseph; Hedy Mameghan; Sandra Turner; John Matthews; Ian Franklin; Chris Atkinson; John North; Michael Poulsen; David Christie; Nigel Spry; Keen-Hun Tai; Chris Wynne; Gillian M Duchesne; Olga Kovacev; Catherine D'Este
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.
The lancet oncology 2005;6(11):841-50.
2005: Bryan H Burmeister; janine thomas; Val Gebski; Lara Fitzgerald; R John Simes; Peter Devitt; Stephen P Ackland; David C Gotley; David Joseph; Jeremy Millar; John North; Euan Walpole; James W Denham
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
The lancet oncology 2005;6(9):659-68.
2005: David S Lamb; James W Denham; Brett Delahunt
Prostate cancer screening in Australasia.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17(4):231-3.
2005: Danny Rischin; Lester Peters; Richard Fisher; Andrew Macann; James W Denham; Michael Poulsen; Michael Jackson; Lizbeth Kenny; Michael Penniment; June Corry; David Lamb; Bev McClure
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):79-87.
2004: G Tsang; Peter O'Brien; R Robertson; Chris Hamilton; Christopher R Wratten; James W Denham
All delays before radiotherapy risk progression of Merkel cell carcinoma.
Australasian radiology 2004;48(3):371-5.
2004: Christopher R Wratten; James W Denham; Tomas Kron; Peter O'Brien; Christopher S Hamilton
'When measurements mean action' decision models for portal image review to eliminate systematic set-up errors.
Australasian radiology 2004;48(2):272-9.
2004: Christopher R Wratten; Janice Kilmurray; Sharon Nash; Michael Seldon; Christopher S Hamilton; Peter C O'Brien; James W Denham
Fatigue during breast radiotherapy and its relationship to biological factors.
International journal of radiation oncology, biology, physics 2004;59(1):160-7.
2004: Peter C O'Brien; Christopher S Hamilton; James W Denham; Ralph Gourlay; C Ian V Franklin
Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2004;58(1):75-80.
2003: David S Lamb; James W Denham; Hedy Mameghan; David Joseph; Sandra Turner; John Matthews; Ian Franklin; Chris Atkinson; John North; Michael Poulsen; Olga Kovacev; Randall Robertson; Lynne Francis; David Christie; Nigel Spry; Keen-Hun Tai; Chris Wynne; Gillian M Duchesne
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(3):255-67.
2003: Tiffany Daly; Michael Poulsen; James W Denham; Lester J Peters; David S Lamb; Hedley Krawitz; Chris Hamilton; Jürg Keller; Lee Tripcony; Quenten Walker
The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(2):113-22.
2003: James W Denham; Allison Steigler; Janice Kilmurray; Christopher R Wratten; Bryan H Burmeister; David S Lamb; David Joseph; Geoff Delaney; David Christie; G Jamieson; janine thomas; Stephen P Ackland; Euan Walpole
Relapse patterns after chemo-radiation for carcinoma of the oesophagus.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2003;15(3):98-108.
2002: Jennette A Sakoff; Esther De Waal; Madhu B Garg; James W Denham; Fiona E Scorgie; Arno Enno; Lisa Lincz; Stephen P Ackland
Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood.
Leukemia & lymphoma 2002;43(10):2017-20.
2002: Peter C O'Brien; C Ian V Franklin; Michael Poulsen; David J Joseph; Nigel Spry; James W Denham
Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group.
International journal of radiation oncology, biology, physics 2002;54(2):442-9.
2002: James W Denham; Martin Hauer-Jensen
The radiotherapeutic injury--a complex 'wound'.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;63(2):129-45.
2002: Wolfgang Dörr; Christopher S Hamilton; Teresa Boyd; Barry Reed; James W Denham
Radiation-induced changes in cellularity and proliferation in human oral mucosa.
International journal of radiation oncology, biology, physics 2002;52(4):911-7.
2002: Tomas Kron; Chris Hamilton; Marianne Roff; James W Denham
Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom.
International journal of radiation oncology, biology, physics 2002;52(2):566-79.
2002: Claire Hood; Lisa Duggan; S Bazley; James W Denham; M Budzanowski; Tomas Kron
LiF:Mg,Cu,P 'pin worms': miniature detectors for brachytherapy dosimetry.
Radiation protection dosimetry 2002;101(1-4):407-10.
2002: Christopher R Wratten; Janice Kilmurray; S Wright; Peter O'Brien; Michael Back; Chris Hamilton; James W Denham
A study of high frequency ultrasound to assess cutaneous oedema in conservatively managed breast.
Frontiers of radiation therapy and oncology 2002;37():121-7.
2001: James W Denham; Tomas Kron
Extinction of the weakest.
International journal of radiation oncology, biology, physics 2001;51(3):807-19.
2001: Michael Poulsen; James W Denham; Lester J Peters; David S Lamb; Nigel Spry; andrew hindley; Hedley Krawitz; Chris Hamilton; Jürg Keller; Lee Tripcony; Quenten Walker
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(2):113-22.
2000: Christopher R Wratten; Janice Kilmurray; S Wright; Peter C O'Brien; Michael Back; Christopher S Hamilton; James W Denham
Pilot study of high-frequency ultrasound to assess cutaneous oedema in the conservatively managed breast.
International journal of cancer. Journal international du cancer 2000;90(5):295-301.
2000: James W Denham; Martin Hauer-Jensen; Tomas Kron; C W Langberg
Treatment-time-dependence models of early and delayed radiation injury in rat small intestine.
International journal of radiation oncology, biology, physics 2000;48(3):871-87.
2000: James W Denham; Tomas Kron; Christopher S Hamilton
A timely reminder.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;56(1):129-30.
2000: Lisa Duggan; Martin J Butson; Stephen Howlett; James W Denham; Tomas Kron
Verification of the dose distribution for 192Ir mould treatments using radiochromic film and LiF:Mg,Cu,P TLDs.
Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine 2000;23(1):15-20.
2000: A See; Tomas Kron; J Johansen; Chris Hamilton; S A Bydder; J Hawkins; M Roff; James W Denham
Decision-making models in the analysis of portal films: a clinical pilot study.
Australasian radiology 2000;44(1):72-83.
2000: Allison Steigler; Hedy Mameghan; David Lamb; David Joseph; John Matthews; Ian Franklin; Sandra Turner; Nigel Spry; Michael Poulsen; John North; Olga Kovacev; James W Denham
A quality assurance audit: phase III trial of maximal androgen deprivation in prostate cancer (TROG 96.01).
Australasian radiology 2000;44(1):65-71.
1999: Michael Poulsen; James W Denham; Nigel Spry; David Lamb; Lester Peters; Hedley Krawitz; Michael Penniment; S Williamson; Lee Tripcony
Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.
Australasian radiology 1999;43(4):487-94.
1999: James W Denham; Lester J Peters; J Johansen; Michael Poulsen; David S Lamb; andrew hindley; P C O'Brien; Nigel Spry; Michael Penniment; Hedley Krawitz; S Williamson; J Bear; Lee Tripcony
Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;52(2):157-64.
1999: James W Denham; Stephen P Ackland; Bryan H Burmeister; Euan Walpole; David S Lamb; P Dady; Nigel Spry
Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapy.
European journal of cancer (Oxford, England : 1990) 1999;35(6):921-7.
1999: Chris Hamilton; Michael Poulsen; Quenten Walker; Hedley Krawitz; andrew hindley; Nigel Spry; Lester Peters; David Lamb; James W Denham; Allison Steigler
Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group.
Australasian radiology 1999;43(2):227-32.
1999: David Lamb; Chris Atkinson; David Joseph; P O'Brien; Stephen P Ackland; A Bonaventura; P Dady; Chris Hamilton; Nigel Spry; J Stewart; James W Denham
Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer.
Australasian radiology 1999;43(2):220-6.
1999: James W Denham; Peter C O'Brien; Hugh Dunstan; J Johansen; A See; Christopher S Hamilton; S Bydder; S Wright
Is there more than one late radiation proctitis syndrome?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;51(1):43-53.
1998: David S Lamb; James W Denham; P E Morum; A J Gray
Long-term results of accelerated radiation treatment for advanced head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;49(1):29-32.
1998: Y Peng; KB Dear; James W Denham
A generalized F mixture model for cure rate estimation.
Statistics in medicine 1998;17(8):813-30.
1998: A See; S Wright; James W Denham
A pilot study of dermofilm in acute radiation-induced desquamative skin reactions.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1998;10(3):182-5.
1998: PM Simonen; Chris Hamilton; S Ferguson; P Ostwald; M O'Brien; Peter O'Brien; Michael Back; James W Denham
Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(1):73-82.
1998: Michael Back; Geoff Delaney; James W Denham; P Graham; Chris Hamilton; G Morgan; Peter O'Brien; P Yuile
How should we introduce high-dose chemotherapeutic strategies into the adjuvant management of high-risk breast cancer in Australasia?
The Australian and New Zealand journal of surgery 1998;68(1):10-5.
1997: Peter C O'Brien; C Ian V Franklin; KB Dear; C C Hamilton; Michael Poulsen; David J Joseph; Nigel Spry; James W Denham
A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(2):117-23.
1997: PM Simonen; M O'Brien; Chris Hamilton; J Ashcroft; James W Denham
Normal variation in cutaneous blood content and red blood cell velocity in humans.
Physiological measurement 1997;18(3):155-70.
1997: James W Denham; Christopher S Hamilton; M O'Brien; PM Ostwald; Tomas Kron; S Wright; Wolfgang Dörr
Erythema: goodbye LQ!
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(2):191-3.
1997: janine thomas; P Devitt; G G Jamieson; JR Bessell; David C Gotley; P G Gill; M Neely; David J Joseph; E K Yeoh; Bryan H Burmeister; James W Denham
A combined modality approach to the management of oesophageal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1997;23(3):219-23.
1997: Christopher S Hamilton; C S Potten; James W Denham; Peter C O'Brien; Tomas Kron; PM Ostwald; S Wright; J Ramsden
Response of human hair cortical cells to fractionated radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(3):289-92.
1996: Tomas Kron; Martin J Butson; F Hunt; James W Denham
TLD extrapolation for skin dose determination in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;41(2):119-23.
1996: James W Denham; Q J Walker; David S Lamb; Christopher S Hamilton; Peter C O'Brien; Nigel Spry; andrew hindley; Michael Poulsen; M O'Brien; Lee Tripcony
Mucosal regeneration during radiotherapy. Trans Tasman Radiation Oncology Group (TROG).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;41(2):109-18.
1996: J MacKean; Bryan H Burmeister; David S Lamb; James W Denham
Concurrent chemoradiation for oesophageal cancer: factors influencing myelotoxicity.
Australasian radiology 1996;40(4):424-9.
1996: James W Denham; Bryan H Burmeister; David S Lamb; Nigel Spry; David J Joseph; Christopher S Hamilton; Eric E K Yeoh; P O'Brien; Q J Walker
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG)
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(1):31-43.
1996: Christopher S Hamilton; James W Denham; M O'Brien; P Ostwald; Tomas Kron; S Wright; W Drr
Underprediction of human skin erythema at low doses per fraction by the linear quadratic model.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(1):23-30.
1996: James W Denham; Christopher S Hamilton; S A Simpson; M O'Brien
Low dose rate teletherapy: updated tumour response.
Australasian radiology 1996;40(2):155-7.
1996: James W Denham; E Denham; Keith Dear; G V Hudson
The follicular non-Hodgkin's lymphomas--II. Prognostic factors: what do they mean?
European journal of cancer (Oxford, England : 1990) 1996;32A(3):480-90.
1996: James W Denham; E Denham; Keith Dear; G V Hudson
The follicular non-Hodgkin's lymphomas--I. The possibility of cure.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):470-9.
1995: P M Ostwald; Tomas Kron; Christopher S Hamilton; James W Denham
Clinical use of carbon-loaded thermoluminescent dosimeters for skin dose determination.
International journal of radiation oncology, biology, physics 1995;33(4):943-50.
1995: James W Denham; Christopher S Hamilton; S A Simpson; P M Ostwald; M O'Brien; Tomas Kron; David J Joseph; Keith Dear
Factors influencing the degree of erythematous skin reactions in humans.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;36(2):107-20.
1995: Bryan H Burmeister; James W Denham; M O'Brien; Glyn G Jamieson; P Grantley Gill; P Devitt; Eric E K Yeoh; Christopher S Hamilton; Stephen P Ackland; David S Lamb
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
International journal of radiation oncology, biology, physics 1995;32(4):997-1006.
1995: James W Denham
How do we bring an acceptable level of radiotherapy services to a dispersed population?
Australasian radiology 1995;39(2):171-3.
1995: James W Denham; Christopher S Hamilton; S A Simpson; M Y O'Brien; P M Ostwald; Tomas Kron; Keith Dear
Acute reaction parameters for human oropharyngeal mucosa.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):129-37.
1995: James W Denham; Christopher S Hamilton; D Christie; M O'Brien; A Bonaventura; J F Stewart; Stephen P Ackland; David S Lamb; Nigel Spry; P Dady
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study.
International journal of radiation oncology, biology, physics 1995;31(2):305-13.
1995: S Ferguson; P Ostwald; Tomas Kron; James W Denham
Verification of surface dose on patients undergoing low to medium energy X-ray therapy.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 1995;20(3):161-5.
1994: P M Ostwald; S G Cooper; James W Denham; Christopher S Hamilton
Dosimetry of high energy electron therapy to the parotid region.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(2):148-56.
1994: James W Denham; H J Dobbs; Christopher S Hamilton
ICRU 50: a commentary.
Australasian radiology 1994;38(3):204-7.
1994: P M Ostwald; P E Metcalfe; James W Denham; Christopher S Hamilton
A comparison of three electron planning algorithms for a 16 MeV electron beam.
International journal of radiation oncology, biology, physics 1994;28(3):731-40.
1993: James W Denham; M J Dally; K Hunter; J Wheat; P P Fahey; Christopher S Hamilton
Objective decision-making following a portal film: the results of a pilot study.
International journal of radiation oncology, biology, physics 1993;26(5):869-76.
1993: Christopher S Hamilton; S A Simpson; S Ferguson; P Ostwald; W Hsu; M O'Brien; James W Denham
Low dose rate teletherapy and tumour response.
Australasian radiology 1993;37(2):210-2.
1993: S G Cooper; A Bonaventura; Stephen P Ackland; David J Joseph; J F Stewart; Christopher S Hamilton; James W Denham
Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1993;5(3):169-73.
1993: Stephen P Ackland; Christopher S Hamilton; David J Joseph; James W Denham
Phase I/II study of concurrent weekly carboplatin and radiation therapy in advanced head and neck cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1993;5(3):133-8.
1992: James W Denham; Christopher S Hamilton; David J Joseph
How should a waiting list for treatment be managed?
Australasian radiology 1992;36(3):274-5.
1992: Christopher S Hamilton; L Y Chan; D L McElwain; James W Denham
A practical evaluation of five dose-volume histogram reduction algorithms.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;24(4):251-60.
1992: P Grantley Gill; James W Denham; Glyn G Jamieson; P G Devitt; Eric E K Yeoh; C Olweny
Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery .
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1037-43.
1992: Christopher S Hamilton; James W Denham
Dose normalisation and specification: from woe to go.
Australasian radiology 1992;36(2):137-41.
1992: Christopher S Hamilton; James W Denham; David J Joseph; David S Lamb; Nigel Spry; A J Gray; C H Atkinson; C J Wynne; A Abdelaal; P V Bydder
Treatment and planning decisions in non-small cell carcinoma of the lung: an Australasian patterns of practice study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1992;4(3):141-7.
1992: P Cross; David J Joseph; J Cant; S G Cooper; James W Denham
Tangential breast irradiation: simple improvements.
International journal of radiation oncology, biology, physics 1992;23(2):433-42.
1991: James W Denham; R W Sillar; D Clarke
Boost dosage to the excision site following conservative surgery for breast cancer: it's easy to miss!
Clinical oncology (Royal College of Radiologists (Great Britain)) 1991;3(5):257-61.
1991: James W Denham; Christopher S Hamilton; P Cross
Breast conservation, the problem of treating the excision site effectively: physical criteria for the choice of technique used.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1991;3(5):250-6.
1991: James W Denham; Christopher S Hamilton; David J Joseph
Patterns of care studies in Australasia.
Australasian radiology 1991;35(2):205.
1991: Christopher S Hamilton; N Piyaratna; S A Ferguson; T M Callaghan; James W Denham
Clinical utility of high-resolution portal films.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1991;3(2):90-5.
1991: James W Denham; R L Abbott
Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):458-63.
1990: Christopher S Hamilton; David J Joseph; A Skov; James W Denham
CT scanning for definitive radiotherapy planning of prostate cancer: necessity or nicety? Results from survey of radiation oncologists working at different institutions in Australasia.
Australasian radiology 1990;34(4):288-92.
1990: P Grantley Gill; Glyn G Jamieson; James W Denham; P G Devitt; A Ahmad; Eric E K Yeoh; A M Jones
Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy.
The British journal of surgery 1990;77(9):1020-3.
1990: S G Cooper; A P Cardew; S Ferguson; David J Joseph; Christopher S Hamilton; James W Denham; A R Williams
Low dose rate teletherapy using a telecaesium 137 unit radiobiological, physical and clinical considerations.
Australasian radiology 1990;34(3):241-6.
1990: David J Joseph; Christopher S Hamilton; James W Denham; Stephen P Ackland; J F Stewart
Whither screening mammography in Australia? Establishing a satisfactory basis for funding.
The Medical journal of Australia 1990;152(10):545-6.
1990: Christopher S Hamilton; James W Denham
The cure of primary prostate cancer by radiotherapy--high-tech quest for a non-existent grail?
Australasian radiology 1990;34(1):5-11.
1989: S G Cooper; James W Denham; Christopher S Hamilton; D J Jospeh; J F Stewart; Stephen P Ackland
The price of a false-negative result of mammography and an overenthusiastic lay press.
The Medical journal of Australia 1989;150(11):664.
1989: P A Reece; I Stafford; R L Abbott; C Anderson; James W Denham; S Freeman; R G Morris; P Grantley Gill; C L Olweny
Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(2):270-5.
1988: James W Denham; M L Carter; P Grantley Gill
Conservative treatment of breast cancer--where should the booster dose go?
International journal of radiation oncology, biology, physics 1988;14(2):399-400.
1988: James W Denham; P Grantley Gill; Glyn G Jamieson; D Hetzel; P Devitt; R Fitch; R Britten-Jones; G E Gibson; R L Abbott; R Hecker
Preliminary experience with a combined-modality approach to the management of oesophageal cancer.
The Medical journal of Australia 1988;148(1):9-13.
1988: James W Denham; A C Baldacchino; J Gutte; R L Nicholls
Remote afterloading techniques for the treatment of nasopharyngeal and endometrial cancer.
International journal of radiation oncology, biology, physics 1988;14(1):191-5.
1987: P C O'Brien; James W Denham; Anthony S-Y Leong
Merkel cell carcinoma: a review of behaviour patterns and management strategies.
The Australian and New Zealand journal of surgery 1987;57(11):847-50.
1986: James W Denham; M L Carter
Location of the excision site following segmental mastectomy for accurate postoperative irradiation.
The Australian and New Zealand journal of surgery 1986;56(9):685-8.
1986: James W Denham; M L Carter
The selection of cases for wedge excision followed by radiotherapy as the treatment of their primary breast cancer.
The Australian and New Zealand journal of surgery 1986;56(1):5-12.